Berard, Roberta A <br/><br/>
Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis.  [electronic resource] 

 -  Expert opinion on biological therapy  Nov 2013 
 - 1623-30 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7682 
<br/><br/><label>Standard No.: </label>10.1517/14712598.2013.840580  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Arthritis, Juvenile--drug therapy<br/>Biological Products--adverse effects<br/>Child<br/>Child, Preschool<br/>Disease-Free Survival<br/>Double-Blind Method<br/>Etanercept<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Infant<br/>Medication Adherence<br/>Multicenter Studies as Topic--statistics & numerical data<br/>Neoplasms--chemically induced<br/>Patient Preference<br/>Product Surveillance, Postmarketing<br/>Quality of Life<br/>Randomized Controlled Trials as Topic--statistics & numerical data<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Registries<br/>Remission Induction<br/>Sample Size<br/>Selection Bias<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors